The therapeutic effect of GM-CSF treatment was mediated through the mobilization of tolerogenic dendritic cells48, which caused the proliferation of Tregs that suppressed the autoimmune disease via increased IL-10 production53. Here, CSF2 is linked to autoimmune disease.